Literature DB >> 9181520

Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene.

M D Mediavilla1, A Güezmez, S Ramos, L Kothari, F Garijo, E J Sánchez Barceló.   

Abstract

The oncostatic effects of melatonin on the mammary gland have been studied in transgenic mice carrying the N-ras proto-oncogene under the control of the MMTV-LTR. Female (4-week-old) virgin mice with positive transgenic pedigrees were injected with melatonin (200 micrograms/mouse/ day, five times a week) or vehicle late in the evening. After 5 months of treatment, animals were sacrificed and the mammary glands were dissected for whole mounts, histology, and immunohistochemical analysis with a mouse monoclonal antibody specific for N-ras protein. Mammary glands of control transgenic mice showed different densities of hyperplastic alveolar nodules (HANs) consisting primarily of dysplastic epithelial cells with nuclear atypia and prominent nucleoli. The epithelial cells of HANs showed a high expression of N-ras while no immunostaining was detected in the unaffected mammary parenchyma. Only one (10%) of the control transgenic mice presented an infiltrating ductal carcinoma with the neoplastic cells overexpressing N-ras protein. The mammary glands of melatonin treated mice had a lower density of HANs, absence of epithelial dysplastic cells, and weak immunostaining of N-ras protein in comparison to the vehicle-treated group. None of the melatonin treated animals developed mammary carcinomas during the observation period. The lymph nodes of the inguinal mammary glands of all the vehicle-treated transgenic mice presented hyperplasia and two animals even had lymphomas, whereas in melatonin-treated animals there was less hyperplasia (two cases were atrophic) and a lack of lymphomas. We conclude that in the mammary glands of MMTV-LTR/N-ras transgenic female virgin mice, melatonin a) reduces the incidence of HANs and the expression of N-ras protein in focal hyperplastic lesions, b) completely prevents the development of epithelial cell atypia and mammary adenocarcinomas, and c) also reduces the hyperplasia of the mammary lymphoid tissue and prevents the development of lymphomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181520     DOI: 10.1111/j.1600-079x.1997.tb00308.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

1.  The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies.

Authors:  Jiaze Hong; Yujing He; Rongrong Fu; Yuexiu Si; Binbin Xu; Jiaxuan Xu; Xiangyuan Li; Feiyan Mao
Journal:  Open Med (Wars)       Date:  2022-04-08

Review 2.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 3.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 4.  The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.

Authors:  Lonnele J Ball; Oxana Palesh; Lance J Kriegsfeld
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 5.  Update on the role of melatonin in the prevention of cancer tumorigenesis and in the management of cancer correlates, such as sleep-wake and mood disturbances: review and remarks.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Simone Perna; Neldo Antoniello
Journal:  Aging Clin Exp Res       Date:  2013-09-18       Impact factor: 3.636

Review 6.  Melatonin and urological cancers: a new therapeutic approach.

Authors:  Mohammad Hossein Mehrzadi; Azam Hosseinzadeh; Kobra Bahrampour Juybari; Saeed Mehrzadi
Journal:  Cancer Cell Int       Date:  2020-09-10       Impact factor: 5.722

7.  Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells.

Authors:  Ming-Ju Hsieh; Chiao-Wen Lin; Shih-Chi Su; Russel J Reiter; Andy Wei-Ge Chen; Mu-Kuan Chen; Shun-Fa Yang
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-09       Impact factor: 8.886

8.  Melatonin anticancer effects: review.

Authors:  Giuseppe Di Bella; Fabrizio Mascia; Luciano Gualano; Luigi Di Bella
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.